Chromatin conformation capture in the clinic: 4C-seq/HiC distinguishes pathogenic from neutral duplications at the GPR101 locus

Adrian F. Daly,Leslie A. Dunnington,David F. Rodriguez-Buritica,Erica Spiegel,Francesco Brancati,Giovanna Mantovani,Vandana M. Rawal,Fabio Rueda Faucz,Hadia Hijazi,Jean-Hubert Caberg,Anna Maria Nardone,Mario Bengala,Paola Fortugno,Giulia Del Sindaco,Marta Ragonese,Helen Gould,Salvatore Cannavò,Patrick Pétrossians,Andrea Lania,James R. Lupski,Albert Beckers,Constantine A. Stratakis,Brynn Levy,Giampaolo Trivellin,Martin Franke
DOI: https://doi.org/10.1186/s13073-024-01378-5
IF: 15.266
2024-09-15
Genome Medicine
Abstract:X-linked acrogigantism (X-LAG; MIM: 300942) is a severe form of pituitary gigantism caused by chromosome Xq26.3 duplications involving GPR101 . X-LAG-associated duplications disrupt the integrity of the topologically associating domain (TAD) containing GPR101 and lead to the formation of a neo-TAD that drives pituitary GPR101 misexpression and gigantism. As X-LAG is fully penetrant and heritable, duplications involving GPR101 identified on prenatal screening studies, like amniocentesis, can pose an interpretation challenge for medical geneticists and raise important concerns for patients and families. Therefore, providing robust information on the functional genomic impact of such duplications has important research and clinical value with respect to gene regulation and triplosensitivity traits.
genetics & heredity
What problem does this paper attempt to address?